Acute disseminated encephalomyelitis (ADEM)-like illness in a pediatric patient following COVID-19 vaccination
Year: 2023
Type: article
Study design: Case Report
Abstract: Since the inception of the COVID-19 pandemic, over 60 cases of acute disseminated encephalomyelitis (ADEM) or ADEM-like clinically isolated syndromes have been linked to COVID-19 infection. However, cases linked to COVID-19 vaccination remain exceptionally rare. To the author's knowledge, eight published cases of ADEM or ADEM-like clinically isolated syndrome have been described after patients received COVID-19 vaccinations, all of which occurred in adults. This report details the first documented case of an ADEM-like illness in a pediatric patient, which developed shortly after receiving the Pfizer (Pfizer-BioNTech, Germany) COVID-19 vaccination. The patient made a near complete clinical recovery over 10 days after receiving a 5-day course of intravenous immunoglobulin therapy.
Source: BJR|case reports
Authors: Kenneth Brock, Susana Creagh Reyes, Christopher Conner, Natalie Gillson, Michael Weiss, Osama Elfituri, Amir Paydar
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $591
OpenAlex ID: W4318988121
